Systematic review: The management of pouchitis

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 8, 2006, Pages 1087-1096

  Pardi, D S ^a,b   Sandborn, W J ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; AZATHIOPRINE; BISMUTH SALICYLATE; BUDESONIDE; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PROBIOTIC AGENT; RIFAMPICIN; RIFAMYCIN; SALAZOSULFAPYRIDINE; SPASMOLYTIC AGENT; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL DISCOMFORT; ALGORITHM; ANUS SPHINCTER; BACTERIAL STRAIN; BACTEROIDES; BALLOON DILATATION; BIFIDOBACTERIUM; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; COLON CROHN DISEASE; CONTRAST ENHANCEMENT; CYTOMEGALOVIRUS INFECTION; DEFECATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DYSGEUSIA; FECES ANALYSIS; FECES INCONTINENCE; FEEDBACK SYSTEM; GASTROINTESTINAL ENDOSCOPY; GENETIC PREDISPOSITION; HUMAN; ILEITIS; ILEOSTOMY; INFORMATION RETRIEVAL; INTESTINE BIOPSY; INTRAVENOUS ADMINISTRATION; LAPAROTOMY; MEDICAL LITERATURE; MEDLINE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PELVIC ORGAN PROLAPSE; PERIPHERAL NEUROPATHY; PERITONEUM ADHESION; POUCHOGRAM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; SURGICAL DRAINAGE; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; COLITIS, ULCERATIVE; HUMANS; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE;

EID: 33646894335     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02884.x     Document Type: Review

References (64)

1. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis and treatment. Gastroenterology 1994 107 : 1856 60.
2. Fazio VW Ziv Y Church JM, et al. Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg 1995 222 : 120 7.
3. Simchuk EJ Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000 24 : 851 6.
4. Salemans JM Nagengast FM Lubbers EJ Kuijpers JH. Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli. Dig Dis Sci 1992 37 : 1882 9.
5. Marcello PW Roberts PL Schoetz DJ Jr. Coller JA Murray JJ Veidenheimer MC. Long-term results of the ileoanal pouch procedure. Arch Surg 1993 128 : 500 3 discussion 503 4.
6. Meagher AP Farouk R Dozois RR Kelly KA Pemberton JH. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998 85 : 800 3.
7. Svaninger G Nordgren S Oresland T Hulten L. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993 28 : 695 700.
8. Shepherd NA Hulten L Tytgat GN, et al. Workshop: Pouchitis. Int J Colorectal Dis 1989 4 : 205 29.
9. Sandborn WJ. Pouchitis: Definition, Risk Factors, Frequency, Natural History, Classification and Public Health Perspective. In : McLeod RS ed Trends in Inflammatory Bowel Disease Therapy, 1996. Hingham, MA, USA : Kluwer Academic Publishers, 1997
10. Sandborn WJ Pardi DS. Clinical management of pouchitis. Gastroenterology 2004 127 : 1809 14.
11. Sagar PM Pemberton JH. Ileo-anal pouch function and dysfunction. Dig Dis 1997 15 : 172 88.
12. Lohmuller JL Pemberton JH Dozois RR Ilstrup D van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990 211 : 622 7 discussion 627 9.
13. Tytgat GN van Deventer SJ. Pouchitis. Int J Colorectal Dis 1988 3 : 226 8.
14. Shen B Achkar JP Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001 121 : 261 7.
15. Hurst RD Molinari M Chung TP Rubin M Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996 131 : 497 500 discussion 501 2.
16. Duffy M O'Mahony L Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002 45 : 384 8.
17. Gosselink MP Schouten WR van Lieshout LM, et al. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004 47 : 1519 25.
18. Gionchetti P Rizzello F Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999 13 : 713 8.
19. Kmiot WA Youngs D Tudor R, et al. Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 1993 80 : 1445 9.
20. Nasmyth DG Godwin PG Dixon MF Williams NS Johnston D. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 1989 96 : 817 24.
21. Schmidt CM Lazenby AJ Hendrickson RJ Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileal anal pull-through procedure. Ann Surg 1998 227 : 654 62.
22. Stahlberg D Gullberg K Liljeqvist L Hellers G Lofberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996 39 : 1012 8.
23. Hata K Watanabe T Shinozaki M Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003 38 : 1055 8.
24. Penna C Dozois R Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996 38 : 234 9.
25. Achkar JP Al-Haddad M Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005 3 : 60 6.
26. Shen B Fazio VW Remzi FH, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005 100 : 93 101.
27. Sandborn WJ Landers CJ Tremaine WJ Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995 90 : 740 7.
28. Carter MJ Di Giovine FS Cox A, et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001 121 : 805 11.
29. Aisenberg J Legnani PE Nilubol N, et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004 99 : 432 41
30. Merrett MN Mortensen N Kettlewell M Jewell DO. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996 38 : 362 4.
31. Di Febo G Miglioli M Lauri A, et al. Endoscopic assessment of acute inflammation of the ileal reservoir after restorative ileo-anal anastomosis. Gastrointest Endosc 1990 36 : 6 9.
32. Moskowitz RL Shepherd NA Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986 1 : 167 74.
33. Shen B Shermock KM Fazio VW, et al. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2003 98 : 2460 7.
34. Shepherd NA Jass JR Duval I Moskowitz RL Nicholls RJ Morson BC. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987 40 : 601 7.
35. Parsi MA Shen B Achkar JP, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004 126 : 1280 6.
36. Johnson MW Dewar DH Ciclitira P Forbes A Nicholls RJ Bjarnason I. Use of fecal lactoferrin to diagnose irritable pouch syndrome: a word of caution. Gastroenterology 2004 127 : 1647 8.
37. Mann SD Pitt J Springall RG Thillainayagam AV. Clostridium difficile infection - an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003 46 : 267 70.
38. Seggerman RE Chen MY Waters GS Ott DJ. Radiology of ileal pouch-anal anastomosis surgery. AJR Am J Roentgenol 2003 180 : 999 1002.
39. Libicher M Scharf J Wunsch A Stern J Dux M Kauffmann GW. MRI of pouch-related fistulas in ulcerative colitis after restorative proctocolectomy. J Comput Assist Tomogr 1998 22 : 664 8.
40. Shen B Lashner BA Bennett AE, et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004 99 : 1527 31.
41. Thompson-Fawcett MW Mortensen NJ Warren BF. ''Cuffitis'' and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis. Dis Colon Rectum 1999 42 : 348 55.
42. Keighley MRB. Review article: The management of pouchitis. Aliment Pharmacol Ther 1996 10 : 449 57.
43. Munoz-Juarez M Pemberton JH Sandborn WJ Tremaine WJ Dozois RR. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999 42 : 117 20.
44. Moonka D Furth EE MacDermott RP Lichtenstein GR. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998 93 : 264 6.
45. Salfiti N Loftus EV Tremaine WJ, et al. Clinical features and outcomes of cytomegalovirus colitis or pouchitis in patients with inflammatory bowel disease. Am J Gastroenterol 2005 100 : S316.
46. Shen B Achkar JP Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002 97 : 972 7.
47. Prudhomme M Dozois RR Godlewski G Mathison S Fabbro-Peray P. Anal canal strictures after ileal pouch-anal anastomosis. Dis Colon Rect 2003 46 : 20 3.
48. Madden MV McIntyre AS Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994 39 : 1193 6.
49. Shen B Achkar JP Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001 7 : 301 5.
50. Sambuelli A Boerr L Negreira S, et al. Budesonide enema in pouchitis - a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002 16 : 27 34.
51. Mimura T Rizzello F Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002 16909 17.
52. Nygaard K Bergan T Bjorneklett A Hoverstad T Lassen J Aase S. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994 29 : 462 7.
53. Gionchetti P Rizzello F Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 305 9.
54. Mimura T Rizzello F Helwig U, et al. Once daily high dose probiotic therapy (VSL #3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 : 108 14.
55. Gionchetti P Rizzello F Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 124 : 1202 9.
56. Shen B Brzezinski A Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005 22 : 721 8.
57. Chopra A Pardi DS Loftus EV, et al. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice. Inflamm Bowel Dis 2006 12 : 29 32.
58. Gionchetti P Rizzello F Morselli C, et al. Eight-week trial of oral budesonide for the treatment of refractory pouchitis. Gastroenterology 2004 126 : A123.
59. Miglioli M Barbara L Di Febo G, et al. Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis. N Engl J Med 1989 320 : 257.
60. Viscido A Habib FI Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch anastomosis for ulcerative colitis. Aliment Pharmacol Ther 2003 17 : 1263 71.
61. Gionchetti P Rizzello F Venturi A, et al. Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis. Aliment Pharmacol Ther 1997 11 : 673 8.
62. Tremaine WJ Sandborn WJ Kenan ML. Bismuth subsalicylate tablets for chronic antibiotic-resistant pouchitis. Gastroenterology 1998 114 : A1101
63. Wischmeyer P Pemberton JH Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993 68 : 978 81.
64. Tremaine WJ Sandborn WJ Wolff BG Carpenter HA Zinsmeister AR Metzger PP. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997 11 : 1041 6.